Find your next paid study

Wake Forest University Health SciencesNCT06958107

~$10 – $750

Actual pay is set by the research site.

Phase 1

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

This Phase 1, multicenter, open-label trial will assess the safety and feasibility of IFx-Hu2.0 as adjunctive therapy to pembrolizumab in adult participant (≥1…

Advanced Or Metastatic Merkel Cell Carcinoma

TuHURA Biosciences, Inc.NCT06940440

~$150 – $4,200

Actual pay is set by the research site.

Neurological DisorderALS (Amyotrophic Lateral Sclerosis)Motor Neuron Disease+2 more

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Synchron, Inc.NCT07543367

~$10 – $1,050

Actual pay is set by the research site.

A Randomized Intervention Trial to Increase Access to Reproductive Health Services Among Adolescents and Young Adults With Intellectual and Developmental Disabilities

The goal of this clinical trial is to test the effectiveness of a 6-week socialization and sex education curriculum (STEPS2) in young people (aged 16-27 years)…

KnowledgeBehavior

City University of New York, School of Public HealthNCT06231485

~$10 – $675

Actual pay is set by the research site.

Phase 3

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) …

Polyarticular Course Juvenile Idiopathic Arthritis (JIA)

Duke UniversityNCT06654882

~$50 – $1,500

Actual pay is set by the research site.

A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Cutaneous Sarcoidosis

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.

Cutaneous Sarcoidosis

Priovant Therapeutics, Inc.NCT06978725

~$75 – $2,800

Actual pay is set by the research site.

Necrotizing FascitisNecrotizing Soft Tissue Infection

The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®

This is a prospective, pilot, parallel group, randomized controlled trial with 1:1 allocation. This will be a single center study coordinated at the Cleveland …

Benjamin T. MillerNCT06857708

~$10 – $1,125

Actual pay is set by the research site.

Obsessive - Compulsive Disorder

Subcortical OCD Neuromodulation With Acoustic Therapy - Dose Duration Optimization

This study is testing a new, non-invasive brain stimulation approach for adults with Obsessive Compulsive Disorder (OCD). Researchers are evaluating the safety…

University of PennsylvaniaNCT07887633

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1b/2 Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan With or Without Other Anticancer Investigational Agents in Participants With Advanced High-Grade Serous or High-Grade Endometrioid Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (REJOICE-Ovarian02)

Researchers are looking for other ways to treat high-grade serous and certain other ovarian cancer. High-grade means the cancer cells grow and spread quickly. …

Ovarian Cancer Recurrent

Merck Sharp & Dohme LLCNCT06843447

~$150 – $4,200

Actual pay is set by the research site.

Strengthening Neuro-Cognitive Skills for Success in School, Work and Beyond

For many Veterans, success in achieving goals at work, school and in other aspects of life are top priorities. The abilities to regulate attention, remember ke…

TBICognitive Dysfunction

VA Office of Research and DevelopmentNCT04109027

~$10 – $675

Actual pay is set by the research site.

Anaplastic Thyroid CarcinomaThyroid CancerThyroid Carcinoma

Pulsed Stereotactic Ablative Radiotherapy (PULSAR) Combined With Targeted Systemic Therapy for Locally Advanced BRAF-V600E+ Anaplastic Thyroid Cancer

This study is a single institution non-randomized phase 2 trial looking at the effect of Pulsed Stereotactic Ablative Radiotherapy (PULSAR) followed by neoadju…

Washington University School of MedicineNCT07886905

~$75 – $2,000

Actual pay is set by the research site.

Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm

DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination With Chemotherapy in Patients With Advanced Solid Tumors

This phase II trial studies the side effects of durvalumab when given together with chemotherapy in treating patients with solid tumors that have spread to oth…